FLUMAZENIL INJECTION

The Defense Logistics Agency awarded a delivery order under contract SPE2DX25D9900 to DMS PHARMACEUTICAL GROUP INC, CAGE 1UNB0, for the supply of FLUMAZENIL INJECTION with NSN 6505013548591 at a contract price of $215.72. The award was issued on July 14, 2026, with a required delivery date of July 29, 2026, and the single line item specifies the delivery of 2.000 PG at a unit price of $107.86, with no variance allowed. Delivery is FOB destination, with the contractor responsible for all transportation costs and risks until receipt at the designated location: Building 1509, West 6th Street, Fort Stewart, GA 31314-5185. Shipment must occur via the fastest traceable means, with parcel post prohibited, and require clear labeling including the MARKFOR designation, tracking number W33RBS61940121, NSN, and CAGE code 32655. Inspection and acceptance occur at the destination, and while the contract references compliance with DLA procedures and federal logistics practices, no specific MIL-STD packaging standards, USP specifications, or formal quality inspection criteria are explicitly stated. The contract contains no identified Section I clauses, Section M evaluation factors, Section K representations or certifications, or Section H special requirements beyond delivery and marking instructions. No payment office details, contracting officer contacts, invoicing method, or applicable appropriation codes are provided. The award is a fixed-price, non-option delivery order with no indication of socioeconomic status, small business designation, or alternate offeror certifications. The procurement is administered under DLA’s procurement system and linked to a larger master contract, reflecting a streamlined logistics transaction for a single pharmaceutical item critical to defense medical supply chains.